ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,116Medicare Part D Prescriptions Filled, Including Refills

Rank: 88 out of 1111

$694K Total Retail Price of All Prescriptions

Rank: 111 out of 1111

431 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 431 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

28% of this provider’s 431 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 10,761 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 743 529 S3 1 1
LEVOTHYROXINE SODIUM 591 536 2 3
OMEPRAZOLE 388 300 3 4
METFORMIN HCL 360 299 4 8
LISINOPRIL 359 321 5 2
SIMVASTATIN 341 287 6 5
AMLODIPINE BESYLATE 317 291 7 7
FUROSEMIDE 246 204 8 6
HYDROCHLOROTHIAZIDE 234 190 9 11
METOPROLOL TARTRATE 229 193 10 12
PRAVASTATIN SODIUM 226 198 11 17
POTASSIUM CHLORIDE 208 182 12 9
METOPROLOL SUCCINATE 187 172 13 20
CITALOPRAM HBR 174 153 14 14
TRAMADOL HCL 171 152 15 13
ZOLPIDEM TARTRATE 171 138 15 16
GABAPENTIN 171 143 15 10
AMLODIPINE BESYLATE-BENAZEPRIL 152 115 18 67
CYMBALTA 150 107 19 40
ATORVASTATIN CALCIUM 143 132 20 15
CARVEDILOL 142 91 21 21
TAMSULOSIN HCL 141 130 22 28
SERTRALINE HCL 137 102 23 24
CRESTOR 136 114 24 33
AZITHROMYCIN 130 104 25 39
WARFARIN SODIUM 129 126 26 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 117 100 27 23
SPIRIVA 116 93 28 53
NEXIUM 101 86 29 26
ALLOPURINOL 96 96 30 36
CLONIDINE HCL 96 74 30 42
PREDNISONE 91 67 32 48
CLOPIDOGREL 84 56 33 30
CYCLOBENZAPRINE HCL 82 46 R 34 37
ATENOLOL 82 69 34 22
LEVOFLOXACIN 81 66 36 88
MELOXICAM 80 46 37 18
ADVAIR DISKUS 80 59 37 43
BENAZEPRIL HCL 80 80 37 97
PROAIR HFA 79 57 40 38
ALENDRONATE SODIUM 77 63 41 35
DIGOXIN 77 65 41 47
ZETIA 73 66 43 109
CELEBREX 71 62 44 81
NAMENDA 71 71 44 31
FLUOXETINE HCL 71 58 44 44
CIPROFLOXACIN HCL 69 62 47 58
LOVASTATIN 68 64 48 41
TRIAMTERENE-HCTZ 63 63 49 80
DONEPEZIL HCL 63 63 49 25
GLIPIZIDE ER 62 62 51 99
DOXAZOSIN MESYLATE 62 62 51 87
RANITIDINE HCL 61 57 53 29
LYRICA 58 58 54 62
LANTUS SOLOSTAR 55 55 55 135
PLAVIX 55 39 55 49
OXYCODONE-ACETAMINOPHEN 54 17 S2 57 147
OXYCODONE HCL 54 42 S2 57 69
GLIPIZIDE 53 41 59 57
ESCITALOPRAM OXALATE 53 40 59 78
JANUVIA 53 51 59 75
AMITRIPTYLINE HCL 51 42 R 62 64
PAROXETINE HCL 51 34 62 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.